Research Pipeline: New Migraine Therapies in Development

You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!


Key Questions
  • What new preventatives are in development?
  • What new acute therapies are in development?
  • When can we expect a cure?
Interview Notes
Deborah Friedman

Deborah Friedman, MD, MPH

Professor of Neurology & Neurotherapeutics and Ophthalmology and Headache Specialist
University of Texas Southwestern Medical Center

Dr. Deborah Friedman is a professor of neurology & neurotherapeutics and ophthalmology at the University of Texas Southwestern Medical Center, where she directs the Headache and Facial Pain Program and the Integrated Project Team for Intracranial Pressure Disorders. She is board-certified in neurology and headache medicine.

Dr. Friedman is also a fellow of the American Academy of Neurology, the American Headache Society, the American Neurological Association and the North American Neuro-Ophthalmology Society. She currently serves on the board of directors of the American Headache Society. She has been elected to the “Best Doctors in America” yearly since 1998 and US News and World Report Top Doctors since 2011.

Unlock full access to the entire 2017 Summit, including:

  • 30+ Expert interviews with audio clips and transcripts
  • Unlimited streaming and downloads
  • Lifetime access with no annual fee
Access Pass options

Related Talks for: Day 6 (2017)

Best Acute Treatments You May Not Have Tried

Lawrence C. Newman, MD

Managing Migraine Emergencies: Avoiding the ER

Richard Lipton, MD

Behavioural Treatments for Migraine

Paul R. Martin, PhD

Neuromodulation: New Devices That Can Ease Pain

Brian Grosberg, MD

You’re Not Alone: What People Don’t Get About Migraine

Lisa Jacobson

Leave a comment


Back to top

Loading...